APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prosthetic Heart Valve & Artificial Heart Valve

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prosthetic Heart Valve & Artificial Heart Valve Market Outlook and Growth Opportunities 2026

21 December 2025217 pages

Choose your research edition.

Industry ResearchProsthetic Heart Valve & Artificial Heart Valve Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Prosthetic Heart Valve & Artificial Heart Valve Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Prosthetic Heart Valve & Artificial Heart Valve Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prosthetic Heart Valve & Artificial Heart Valve Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Prosthetic Heart Valve & Artificial Heart Valve Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Prosthetic Heart Valve & Artificial Heart Valve market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prosthetic Heart Valve & Artificial Heart Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prosthetic Heart Valve & Artificial Heart Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prosthetic Heart Valve & Artificial Heart Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prosthetic Heart Valve & Artificial Heart Valve market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prosthetic Heart Valve & Artificial Heart Valve market include Medtronic Plc, Medtronic, Boston Scientific Corporation, TTK Healthcare Limited (A Ttk Group Company), Ttk Healthcare Limited, Symetis Sa, Symetis, St. Jude Medical, Inc. (An Abbott Laboratories Company) and St. Jude Medical Inc. (Abbott Laboratories Company), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prosthetic Heart Valve & Artificial Heart Valve market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prosthetic Heart Valve & Artificial Heart Valve and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prosthetic Heart Valve & Artificial Heart Valve sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prosthetic Heart Valve & Artificial Heart Valve market size, projected growth trends, production technologies, key applications, and end-use industries.

Prosthetic Heart Valve & Artificial Heart Valve Segment by Company

Medtronic Plc

Medtronic

Boston Scientific Corporation

TTK Healthcare Limited (A Ttk Group Company)

Ttk Healthcare Limited

Symetis Sa

Symetis

St. Jude Medical, Inc. (An Abbott Laboratories Company)

St. Jude Medical Inc. (Abbott Laboratories Company)

Micro Interventional Devices

Meril Life Sciences

Livanova Plc

Livanova Plc

Lepu Medical Technology Co., Ltd.

Lepu Medical Technology

Labcor Laboratório

Jenavalve Technology, Inc.

Jenavalve Technology Inc.

HLT Inc. (A Bracco Group Company)

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

Cryolife, Inc.

Cryolife Inc.

Comed B.V.

Colibri Heart Valve, Llc

Colibri Heart Valve

Braile Biomédica

Braile Biomédica

Boston Scientific Corporation

Autotissue Berlin Gmbh

Prosthetic Heart Valve & Artificial Heart Valve Segment by Type

Mechanical Heart Valve

Transcatheter Heart Valve

Tissue Heart Valve

Prosthetic Heart Valve & Artificial Heart Valve Segment by Application

Congenital Heart Disease

Marfan Syndrome

Rheumatic Heart Disease

Other

Prosthetic Heart Valve & Artificial Heart Valve Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prosthetic Heart Valve & Artificial Heart Valve status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prosthetic Heart Valve & Artificial Heart Valve market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prosthetic Heart Valve & Artificial Heart Valve significant trends, drivers, influence factors in global and regions.

6. To analyze Prosthetic Heart Valve & Artificial Heart Valve competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prosthetic Heart Valve & Artificial Heart Valve market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prosthetic Heart Valve & Artificial Heart Valve and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prosthetic Heart Valve & Artificial Heart Valve.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prosthetic Heart Valve & Artificial Heart Valve market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prosthetic Heart Valve & Artificial Heart Valve industry.

Chapter 3: Detailed analysis of Prosthetic Heart Valve & Artificial Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prosthetic Heart Valve & Artificial Heart Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prosthetic Heart Valve & Artificial Heart Valve in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prosthetic Heart Valve & Artificial Heart Valve Industry Trends Table 2. Prosthetic Heart Valve & Artificial Heart Valve Industry Drivers Table 3. Prosthetic Heart Valve & Artificial Heart Valve Industry Opportunities and Challenges Table 4. Prosthetic Heart Valve & Artificial Heart Valve Industry Restraints Table 5. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Company (2021-2026) Table 7. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Company (units) & (2021-2026) Table 8. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Company (2021-2026) Table 9. Global Prosthetic Heart Valve & Artificial Heart Valve Average Price (US$/unit) of Company (2021-2026) Table 10. Global Prosthetic Heart Valve & Artificial Heart Valve Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prosthetic Heart Valve & Artificial Heart Valve Key Company Manufacturing Base & Headquarters Table 12. Global Prosthetic Heart Valve & Artificial Heart Valve Company, Product Type & Application Table 13. Global Prosthetic Heart Valve & Artificial Heart Valve Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prosthetic Heart Valve & Artificial Heart Valve by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Mechanical Heart Valve Table 18. Significant Companies of Transcatheter Heart Valve Table 19. Significant Companies of Tissue Heart Valve Table 20. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Type (2021-2026) & (units) Table 22. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Type (2027-2032) & (units) Table 23. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Type (2021-2026) Table 24. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Type (2027-2032) Table 25. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type (2021-2026) Table 29. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Congenital Heart Disease Table 31. Significant Companies of Marfan Syndrome Table 32. Significant Companies of Rheumatic Heart Disease Table 33. Significant Companies of Other Table 34. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 35. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Application (2021-2026) & (units) Table 36. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Application (2027-2032) & (units) Table 37. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Application (2021-2026) Table 38. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Application (2027-2032) Table 39. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application (2021-2026) Table 43. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application (2027-2032) Table 44. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2021 VS 2025 VS 2032 (units) Table 45. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2021-2026) & (units) Table 46. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Region (2021-2026) Table 47. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2027-2032) & (units) Table 48. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Region (2027-2032) Table 49. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Region (2021-2026) Table 52. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Region (2027-2032) Table 54. Global Prosthetic Heart Valve & Artificial Heart Valve Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Prosthetic Heart Valve & Artificial Heart Valve Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Country: 2021 VS 2025 VS 2032 (units) Table 57. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2021-2026) & (units) Table 59. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Country (2021-2026) Table 60. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2027-2032) & (units) Table 61. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Country (2027-2032) Table 62. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Market Share by Country (2021-2026) Table 64. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Market Share by Country (2027-2032) Table 66. Medtronic Plc Company Information Table 67. Medtronic Plc Business Overview Table 68. Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 70. Medtronic Plc Recent Development Table 71. Medtronic Company Information Table 72. Medtronic Business Overview Table 73. Medtronic Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Medtronic Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 75. Medtronic Recent Development Table 76. Boston Scientific Corporation Company Information Table 77. Boston Scientific Corporation Business Overview Table 78. Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 80. Boston Scientific Corporation Recent Development Table 81. TTK Healthcare Limited (A Ttk Group Company) Company Information Table 82. TTK Healthcare Limited (A Ttk Group Company) Business Overview Table 83. TTK Healthcare Limited (A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. TTK Healthcare Limited (A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 85. TTK Healthcare Limited (A Ttk Group Company) Recent Development Table 86. Ttk Healthcare Limited Company Information Table 87. Ttk Healthcare Limited Business Overview Table 88. Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 90. Ttk Healthcare Limited Recent Development Table 91. Symetis Sa Company Information Table 92. Symetis Sa Business Overview Table 93. Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 95. Symetis Sa Recent Development Table 96. Symetis Company Information Table 97. Symetis Business Overview Table 98. Symetis Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Symetis Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 100. Symetis Recent Development Table 101. St. Jude Medical, Inc. (An Abbott Laboratories Company) Company Information Table 102. St. Jude Medical, Inc. (An Abbott Laboratories Company) Business Overview Table 103. St. Jude Medical, Inc. (An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. St. Jude Medical, Inc. (An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 105. St. Jude Medical, Inc. (An Abbott Laboratories Company) Recent Development Table 106. St. Jude Medical Inc. (Abbott Laboratories Company) Company Information Table 107. St. Jude Medical Inc. (Abbott Laboratories Company) Business Overview Table 108. St. Jude Medical Inc. (Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. St. Jude Medical Inc. (Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 110. St. Jude Medical Inc. (Abbott Laboratories Company) Recent Development Table 111. Micro Interventional Devices Company Information Table 112. Micro Interventional Devices Business Overview Table 113. Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 115. Micro Interventional Devices Recent Development Table 116. Meril Life Sciences Company Information Table 117. Meril Life Sciences Business Overview Table 118. Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 120. Meril Life Sciences Recent Development Table 121. Livanova Plc Company Information Table 122. Livanova Plc Business Overview Table 123. Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 125. Livanova Plc Recent Development Table 126. Livanova Plc Company Information Table 127. Livanova Plc Business Overview Table 128. Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 130. Livanova Plc Recent Development Table 131. Lepu Medical Technology Co., Ltd. Company Information Table 132. Lepu Medical Technology Co., Ltd. Business Overview Table 133. Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 135. Lepu Medical Technology Co., Ltd. Recent Development Table 136. Lepu Medical Technology Company Information Table 137. Lepu Medical Technology Business Overview Table 138. Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 140. Lepu Medical Technology Recent Development Table 141. Labcor Laboratório Company Information Table 142. Labcor Laboratório Business Overview Table 143. Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 145. Labcor Laboratório Recent Development Table 146. Jenavalve Technology, Inc. Company Information Table 147. Jenavalve Technology, Inc. Business Overview Table 148. Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 150. Jenavalve Technology, Inc. Recent Development Table 151. Jenavalve Technology Inc. Company Information Table 152. Jenavalve Technology Inc. Business Overview Table 153. Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 155. Jenavalve Technology Inc. Recent Development Table 156. HLT Inc. (A Bracco Group Company) Company Information Table 157. HLT Inc. (A Bracco Group Company) Business Overview Table 158. HLT Inc. (A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. HLT Inc. (A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 160. HLT Inc. (A Bracco Group Company) Recent Development Table 161. Edwards Lifesciences Corporation Company Information Table 162. Edwards Lifesciences Corporation Business Overview Table 163. Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 165. Edwards Lifesciences Corporation Recent Development Table 166. Edwards Lifesciences Corporation Company Information Table 167. Edwards Lifesciences Corporation Business Overview Table 168. Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 170. Edwards Lifesciences Corporation Recent Development Table 171. Cryolife, Inc. Company Information Table 172. Cryolife, Inc. Business Overview Table 173. Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 174. Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 175. Cryolife, Inc. Recent Development Table 176. Cryolife Inc. Company Information Table 177. Cryolife Inc. Business Overview Table 178. Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 179. Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 180. Cryolife Inc. Recent Development Table 181. Comed B.V. Company Information Table 182. Comed B.V. Business Overview Table 183. Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 184. Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 185. Comed B.V. Recent Development Table 186. Colibri Heart Valve, Llc Company Information Table 187. Colibri Heart Valve, Llc Business Overview Table 188. Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 189. Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 190. Colibri Heart Valve, Llc Recent Development Table 191. Colibri Heart Valve Company Information Table 192. Colibri Heart Valve Business Overview Table 193. Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 194. Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 195. Colibri Heart Valve Recent Development Table 196. Braile Biomédica Company Information Table 197. Braile Biomédica Business Overview Table 198. Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 199. Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 200. Braile Biomédica Recent Development Table 201. Braile Biomédica Company Information Table 202. Braile Biomédica Business Overview Table 203. Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 204. Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 205. Braile Biomédica Recent Development Table 206. Boston Scientific Corporation Company Information Table 207. Boston Scientific Corporation Business Overview Table 208. Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 209. Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 210. Boston Scientific Corporation Recent Development Table 211. Autotissue Berlin Gmbh Company Information Table 212. Autotissue Berlin Gmbh Business Overview Table 213. Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 214. Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio Table 215. Autotissue Berlin Gmbh Recent Development Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Prosthetic Heart Valve & Artificial Heart Valve Distributors List Table 219. Prosthetic Heart Valve & Artificial Heart Valve Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Prosthetic Heart Valve & Artificial Heart Valve Product Image Figure 2. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prosthetic Heart Valve & Artificial Heart Valve Sales (2021-2032) & (units) Figure 5. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Prosthetic Heart Valve & Artificial Heart Valve Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Mechanical Heart Valve Image Figure 10. Transcatheter Heart Valve Image Figure 11. Tissue Heart Valve Image Figure 12. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Type (2021-2032) Figure 15. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type (2021-2032) Figure 18. Congenital Heart Disease Image Figure 19. Marfan Syndrome Image Figure 20. Rheumatic Heart Disease Image Figure 21. Other Image Figure 22. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 23. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Application (2021-2032) Figure 25. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application (2021-2032) Figure 28. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 29. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032) & (US$ Million) Figure 33. North America Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032) & (US$ Million) Figure 39. South America Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025

Scope & coverage.

Types
  • Mechanical Heart Valve
  • Transcatheter Heart Valve
  • Tissue Heart Valve
Applications
  • Congenital Heart Disease
  • Marfan Syndrome
  • Rheumatic Heart Disease
  • Other
Companies covered
  • Medtronic Plc
  • Medtronic
  • Boston Scientific Corporation
  • TTK Healthcare Limited (A Ttk Group Company)
  • Ttk Healthcare Limited
  • Symetis Sa
  • Symetis
  • St. Jude Medical, Inc. (An Abbott Laboratories Company)
  • St. Jude Medical Inc. (Abbott Laboratories Company)
  • Micro Interventional Devices
  • Meril Life Sciences
  • Livanova Plc
  • Livanova Plc
  • Lepu Medical Technology Co., Ltd.
  • Lepu Medical Technology
  • Labcor Laboratório
  • Jenavalve Technology, Inc.
  • Jenavalve Technology Inc.
  • HLT Inc. (A Bracco Group Company)
  • Edwards Lifesciences Corporation
  • Edwards Lifesciences Corporation
  • Cryolife, Inc.
  • Cryolife Inc.
  • Comed B.V.
  • Colibri Heart Valve, Llc
  • Colibri Heart Valve
  • Braile Biomédica
  • Braile Biomédica
  • Boston Scientific Corporation
  • Autotissue Berlin Gmbh

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032)
  4. 1.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume (2021-2032)
  5. 1.2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prosthetic Heart Valve & Artificial Heart Valve Market Dynamics
  1. 2.1 Prosthetic Heart Valve & Artificial Heart Valve Industry Trends
  2. 2.2 Prosthetic Heart Valve & Artificial Heart Valve Industry Drivers
  3. 2.3 Prosthetic Heart Valve & Artificial Heart Valve Industry Opportunities and Challenges
  4. 2.4 Prosthetic Heart Valve & Artificial Heart Valve Industry Restraints
3 Prosthetic Heart Valve & Artificial Heart Valve Market by Company
  1. 3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Company Revenue Ranking in 2025
  2. 3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Company (2021-2026)
  3. 3.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Company (2021-2026)
  4. 3.4 Global Prosthetic Heart Valve & Artificial Heart Valve Average Price by Company (2021-2026)
  5. 3.5 Global Prosthetic Heart Valve & Artificial Heart Valve Company Ranking (2024-2026)
  6. 3.6 Global Prosthetic Heart Valve & Artificial Heart Valve Company Manufacturing Base and Headquarters
  7. 3.7 Global Prosthetic Heart Valve & Artificial Heart Valve Company Product Type and Application
  8. 3.8 Global Prosthetic Heart Valve & Artificial Heart Valve Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prosthetic Heart Valve & Artificial Heart Valve Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prosthetic Heart Valve & Artificial Heart Valve Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prosthetic Heart Valve & Artificial Heart Valve Market by Type
  1. 4.1 Prosthetic Heart Valve & Artificial Heart Valve Type Introduction
  2. 4.1.1 Mechanical Heart Valve
  3. 4.1.2 Transcatheter Heart Valve
  4. 4.1.3 Tissue Heart Valve
  5. 4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Type
  6. 4.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Type
  10. 4.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Type (2021-2032)
  12. 4.3.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type (2021-2032)
5 Prosthetic Heart Valve & Artificial Heart Valve Market by Application
  1. 5.1 Prosthetic Heart Valve & Artificial Heart Valve Application Introduction
  2. 5.1.1 Congenital Heart Disease
  3. 5.1.2 Marfan Syndrome
  4. 5.1.3 Rheumatic Heart Disease
  5. 5.1.4 Other
  6. 5.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Application
  7. 5.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Application
  11. 5.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Application (2021-2032)
  13. 5.3.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application (2021-2032)
6 Prosthetic Heart Valve & Artificial Heart Valve Regional Sales and Value Analysis
  1. 6.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2021-2032)
  3. 6.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2021-2026
  4. 6.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2027-2032)
  5. 6.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Region (2027-2032)
  9. 6.5 Global Prosthetic Heart Valve & Artificial Heart Valve Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032)
  12. 6.6.2 North America Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032)
  15. 6.7.2 Europe Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032)
  21. 6.9.2 South America Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prosthetic Heart Valve & Artificial Heart Valve Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Country, 2025 VS 2032
7 Prosthetic Heart Valve & Artificial Heart Valve Country-level Sales and Value Analysis
  1. 7.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2021-2032)
  4. 7.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2021-2026)
  5. 7.3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2027-2032)
  6. 7.4 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prosthetic Heart Valve & Artificial Heart Valve Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prosthetic Heart Valve & Artificial Heart Valve Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic Plc
  2. 8.1.1 Medtronic Plc Company Information
  3. 8.1.2 Medtronic Plc Business Overview
  4. 8.1.3 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  6. 8.1.5 Medtronic Plc Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Boston Scientific Corporation
  14. 8.3.1 Boston Scientific Corporation Company Information
  15. 8.3.2 Boston Scientific Corporation Business Overview
  16. 8.3.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  18. 8.3.5 Boston Scientific Corporation Recent Developments
  19. 8.4 TTK Healthcare Limited (A Ttk Group Company)
  20. 8.4.1 TTK Healthcare Limited (A Ttk Group Company) Company Information
  21. 8.4.2 TTK Healthcare Limited (A Ttk Group Company) Business Overview
  22. 8.4.3 TTK Healthcare Limited (A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TTK Healthcare Limited (A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  24. 8.4.5 TTK Healthcare Limited (A Ttk Group Company) Recent Developments
  25. 8.5 Ttk Healthcare Limited
  26. 8.5.1 Ttk Healthcare Limited Company Information
  27. 8.5.2 Ttk Healthcare Limited Business Overview
  28. 8.5.3 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  30. 8.5.5 Ttk Healthcare Limited Recent Developments
  31. 8.6 Symetis Sa
  32. 8.6.1 Symetis Sa Company Information
  33. 8.6.2 Symetis Sa Business Overview
  34. 8.6.3 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  36. 8.6.5 Symetis Sa Recent Developments
  37. 8.7 Symetis
  38. 8.7.1 Symetis Company Information
  39. 8.7.2 Symetis Business Overview
  40. 8.7.3 Symetis Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Symetis Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  42. 8.7.5 Symetis Recent Developments
  43. 8.8 St. Jude Medical, Inc. (An Abbott Laboratories Company)
  44. 8.8.1 St. Jude Medical, Inc. (An Abbott Laboratories Company) Company Information
  45. 8.8.2 St. Jude Medical, Inc. (An Abbott Laboratories Company) Business Overview
  46. 8.8.3 St. Jude Medical, Inc. (An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 St. Jude Medical, Inc. (An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  48. 8.8.5 St. Jude Medical, Inc. (An Abbott Laboratories Company) Recent Developments
  49. 8.9 St. Jude Medical Inc. (Abbott Laboratories Company)
  50. 8.9.1 St. Jude Medical Inc. (Abbott Laboratories Company) Company Information
  51. 8.9.2 St. Jude Medical Inc. (Abbott Laboratories Company) Business Overview
  52. 8.9.3 St. Jude Medical Inc. (Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 St. Jude Medical Inc. (Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  54. 8.9.5 St. Jude Medical Inc. (Abbott Laboratories Company) Recent Developments
  55. 8.10 Micro Interventional Devices
  56. 8.10.1 Micro Interventional Devices Company Information
  57. 8.10.2 Micro Interventional Devices Business Overview
  58. 8.10.3 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  60. 8.10.5 Micro Interventional Devices Recent Developments
  61. 8.11 Meril Life Sciences
  62. 8.11.1 Meril Life Sciences Company Information
  63. 8.11.2 Meril Life Sciences Business Overview
  64. 8.11.3 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  66. 8.11.5 Meril Life Sciences Recent Developments
  67. 8.12 Livanova Plc
  68. 8.12.1 Livanova Plc Company Information
  69. 8.12.2 Livanova Plc Business Overview
  70. 8.12.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  72. 8.12.5 Livanova Plc Recent Developments
  73. 8.13 Livanova Plc
  74. 8.13.1 Livanova Plc Company Information
  75. 8.13.2 Livanova Plc Business Overview
  76. 8.13.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  78. 8.13.5 Livanova Plc Recent Developments
  79. 8.14 Lepu Medical Technology Co., Ltd.
  80. 8.14.1 Lepu Medical Technology Co., Ltd. Company Information
  81. 8.14.2 Lepu Medical Technology Co., Ltd. Business Overview
  82. 8.14.3 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  84. 8.14.5 Lepu Medical Technology Co., Ltd. Recent Developments
  85. 8.15 Lepu Medical Technology
  86. 8.15.1 Lepu Medical Technology Company Information
  87. 8.15.2 Lepu Medical Technology Business Overview
  88. 8.15.3 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  90. 8.15.5 Lepu Medical Technology Recent Developments
  91. 8.16 Labcor Laboratório
  92. 8.16.1 Labcor Laboratório Company Information
  93. 8.16.2 Labcor Laboratório Business Overview
  94. 8.16.3 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  96. 8.16.5 Labcor Laboratório Recent Developments
  97. 8.17 Jenavalve Technology, Inc.
  98. 8.17.1 Jenavalve Technology, Inc. Company Information
  99. 8.17.2 Jenavalve Technology, Inc. Business Overview
  100. 8.17.3 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  102. 8.17.5 Jenavalve Technology, Inc. Recent Developments
  103. 8.18 Jenavalve Technology Inc.
  104. 8.18.1 Jenavalve Technology Inc. Company Information
  105. 8.18.2 Jenavalve Technology Inc. Business Overview
  106. 8.18.3 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  108. 8.18.5 Jenavalve Technology Inc. Recent Developments
  109. 8.19 HLT Inc. (A Bracco Group Company)
  110. 8.19.1 HLT Inc. (A Bracco Group Company) Company Information
  111. 8.19.2 HLT Inc. (A Bracco Group Company) Business Overview
  112. 8.19.3 HLT Inc. (A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 HLT Inc. (A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  114. 8.19.5 HLT Inc. (A Bracco Group Company) Recent Developments
  115. 8.20 Edwards Lifesciences Corporation
  116. 8.20.1 Edwards Lifesciences Corporation Company Information
  117. 8.20.2 Edwards Lifesciences Corporation Business Overview
  118. 8.20.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  120. 8.20.5 Edwards Lifesciences Corporation Recent Developments
  121. 8.21 Edwards Lifesciences Corporation
  122. 8.21.1 Edwards Lifesciences Corporation Company Information
  123. 8.21.2 Edwards Lifesciences Corporation Business Overview
  124. 8.21.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  126. 8.21.5 Edwards Lifesciences Corporation Recent Developments
  127. 8.22 Cryolife, Inc.
  128. 8.22.1 Cryolife, Inc. Company Information
  129. 8.22.2 Cryolife, Inc. Business Overview
  130. 8.22.3 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  132. 8.22.5 Cryolife, Inc. Recent Developments
  133. 8.23 Cryolife Inc.
  134. 8.23.1 Cryolife Inc. Company Information
  135. 8.23.2 Cryolife Inc. Business Overview
  136. 8.23.3 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  138. 8.23.5 Cryolife Inc. Recent Developments
  139. 8.24 Comed B.V.
  140. 8.24.1 Comed B.V. Company Information
  141. 8.24.2 Comed B.V. Business Overview
  142. 8.24.3 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  144. 8.24.5 Comed B.V. Recent Developments
  145. 8.25 Colibri Heart Valve, Llc
  146. 8.25.1 Colibri Heart Valve, Llc Company Information
  147. 8.25.2 Colibri Heart Valve, Llc Business Overview
  148. 8.25.3 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  150. 8.25.5 Colibri Heart Valve, Llc Recent Developments
  151. 8.26 Colibri Heart Valve
  152. 8.26.1 Colibri Heart Valve Company Information
  153. 8.26.2 Colibri Heart Valve Business Overview
  154. 8.26.3 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  156. 8.26.5 Colibri Heart Valve Recent Developments
  157. 8.27 Braile Biomédica
  158. 8.27.1 Braile Biomédica Company Information
  159. 8.27.2 Braile Biomédica Business Overview
  160. 8.27.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  162. 8.27.5 Braile Biomédica Recent Developments
  163. 8.28 Braile Biomédica
  164. 8.28.1 Braile Biomédica Company Information
  165. 8.28.2 Braile Biomédica Business Overview
  166. 8.28.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  168. 8.28.5 Braile Biomédica Recent Developments
  169. 8.29 Boston Scientific Corporation
  170. 8.29.1 Boston Scientific Corporation Company Information
  171. 8.29.2 Boston Scientific Corporation Business Overview
  172. 8.29.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  173. 8.29.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  174. 8.29.5 Boston Scientific Corporation Recent Developments
  175. 8.30 Autotissue Berlin Gmbh
  176. 8.30.1 Autotissue Berlin Gmbh Company Information
  177. 8.30.2 Autotissue Berlin Gmbh Business Overview
  178. 8.30.3 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Sales, Value and Gross Margin (2021-2026)
  179. 8.30.4 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
  180. 8.30.5 Autotissue Berlin Gmbh Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prosthetic Heart Valve & Artificial Heart Valve Value Chain Analysis
  2. 9.1.1 Prosthetic Heart Valve & Artificial Heart Valve Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prosthetic Heart Valve & Artificial Heart Valve Sales Mode & Process
  6. 9.2 Prosthetic Heart Valve & Artificial Heart Valve Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prosthetic Heart Valve & Artificial Heart Valve Distributors
  9. 9.2.3 Prosthetic Heart Valve & Artificial Heart Valve Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst